CAS 72800-72-7: Panaxydol

Panaxydol is a bioactive compound, which is an acetylene derivative isolated from the roots of Panax ginseng. This compound is primarily sourced from the ginseng plant, known for its ethnobotanical uses and pharmacological activities. The mode of action of Panaxydol is believed to involve the modulation of cellular signaling pathways, including inhibition of cell proliferation and induction of apoptosis in cancer cells. This effect on cell cycle regulation and apoptosis suggests its potential as an anticancer agent. Additionally, Panaxydol exhibits anti-inflammatory properties by inhibiting the synthesis of pro-inflammatory cytokines and mediators, making it of interest in managing inflammatory conditions. The applications of Panaxydol are currently under extensive study in the context of cancer therapy, inflammation, and possibly other chronic diseases, reflecting its versatile biological activity and potential as a therapeutic compound. Research efforts continue to elucidate the full spectrum of its pharmacodynamics and therapeutic windows in preclinical and clinical settings.

Panaxydol has anti-cancer activity, can inhibit the growth and apoptosis of cancer cells, the signaling mechanisms involve a [Ca(2+)](i) increase, JNK and p38